Clinical effect of ultrasound-guided injection of lauromacrogol versus anhydrous ethanol as sclerotherapy for simple hepatic cyst:a therapeutic effect analysis and comparative study

Dong JinBin; Shi YiHai; Fang WeiBing

doi:10.3969/j.issn.1001-5256.2016.06.029

Issue 6

Jun. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(6): 1160-1164

PDF( 221 KB)

Clinical effect of ultrasound-guided injection of lauromacrogol versus anhydrous ethanol as sclerotherapy for simple hepatic cyst:a therapeutic effect analysis and comparative study

DOI: 10.3969/j.issn.1001-5256.2016.06.029

Published Date: 2016-06-20

Abstract

Abstract

Objective To investigate the clinical effect of ultrasound- guided injection of lauromacrogol versus anhydrous ethanol as the sclerotherapy for simple hepatic cyst,as well as the incidence rates of adverse events and changes in liver function and the results of routine blood test after surgery,and to evaluate the advantages and disadvantages of these two sclerosing agents in the treatment of simple hepatic cyst.Methods A total of 62 patients with simple hepatic cyst who were treated in Department of Gastroenterology,Shanghai Pudong New Area Gongli Hospital were enrolled and randomly divided into observation group(lauromacrogol group) and control group(anhydrous ethanol group).The patients in these two groups were given ultrasound- guided injection of lauromacrogol and anhydrous ethanol,respectively.The incidence rates of intraoperative and postoperative adverse events,cure rate,changes in the serum levels of serum total bilirubin(TBil),alanine aminotransferase(ALT),aspartate aminotransferase(AST),cholinesterase(CHE),and alkaline phosphatase(ALP),and changes in the results of routine blood test within 24 hours after surgery were compared between the two groups.The t- test was used for comparison of continuous data between groups,and the chi- square test was used for comparison of categorical data between groups.Results Compared with the control group,the observation group had significantly lower incidence rates of adverse events and a significantly lower blood alcohol concentration(both P < 0.05).The cure rate(1 and 6 months after surgery) and the changes in the results of routine blood test within 24 hours after surgery showed no significant differences between the two groups(both P > 0.05).At 1 week after surgery,the serum levels of ALT and AST showed significant differences between the observation group and the control group for single hepatic cyst(t =- 3.680 and- 5.571,P = 0.001 and < 0.001),while the serum levels of ALT and AST showed significant differences between the observation group and the control group for multiple hepatic cysts(t =- 2.156 and- 4.626,P = 0.040 and < 0.001).Conclusion Ultrasound- guided injection of lauromacrogol or anhydrous ethanol as the sclerotherapy for simple hepatic cyst is safe and effective,with mild injury and a relatively high clinical cure rate.However,compared with anhydrous ethanol,lauromacrogol causes significantly fewer adverse events and milder adverse effects on liver function.As for patients with multiple hepatic cysts and poor hepatic functional reserve,lauromacrogol has obvious superiority and can be used as the first- line sclerosing agent.
- hepatic cyst,
- punctures,
- polidocanol,
- anhydrous ethanol,
- comparative study

FullText(HTML)

References(11)

References

[1]TOCCHI A,MAZZONI G,GOSTA G,et al.Symtomatic nonparasitic liver cysts:options for and results of surgical treatment[J].Arch Surg,2002,137(2):154-158.

[2]ZHANG WB,CHEN J,YAN ZH,et al.Effect of ultrasoundguided sclerotherapy with lauromacrogol or anhydrous ethanol in treatment of simple hepatic cyst:a comparative analysis[J].The JPract Med,2014,30(8):1312-1315.(in Chinese)张卫兵,陈建,颜朝晖,等.超声引导下聚桂醇与无水乙醇硬化治疗单纯性肝囊肿的比较[J].实用医学杂志,2014,30(8):1312-1315.

[3]ZHANG Q,QIAN LX,HE W,et al.The effect of three kinds of alcohol sclerotherapy in simple hepatic and kindey cysts[J].Chin JMed Imaging Technol,2007,23(10):1555-1557.(in Chinese)张庆,钱林学,贺文,等.单纯性肝肾囊肿三种酒精硬化治疗方法临床疗效[J].中国医学影像技术,2007,23(10):1555-1557.

[4]XIA GB,HU CH.Value of lauromacrogol as a new sclerosing agent in sclerotherapy for simple liver and kidney cysts[J].Diagn Imag Interv Radiol,2013,22(1):47-50.(in Chinese)夏国兵,胡春洪.新型硬化剂-聚桂醇在单纯性肝肾囊肿硬化治疗中的应用价值[J].影像诊断与介入放射学,2013,22(1):47-50.

[5]MONFREUX A.Traitement sclérosant des troncs saphèniens et leurs collatérales de gros calibres par la méthode[J].MUS,Phlébologie,1997,50:351-353.

[6]WANG SS,CHEN P,CHU ZY,et al.Large-dose absolute ethanol sclerotherapy with ultrasound-guided catheterization for huge liver cyst[J].Chin J Min Inv Surg,2012,12(7):618-620.(in Chinese)王树松,陈萍,楚昭莹,等.超声引导置管大剂量无水乙醇硬化治疗巨大肝囊肿[J].中国微创外科杂志,2012,12(7):618-620.

[7]WAHBA R,KLEINERT R,PREZEL K,et al.Laparoscopic deroofing of non-parasitic liver cysts with or without greater omentum flap[J].Surg Endosc,2011,25(1):54-58.

[8]ORNISI C,BROTTO M.Immediate pathologic effects on the vein wall of foam sclerotherapy[J].Dermatol Surg,2007,33(10):1250.

[9]FAN XY.Ultrasound-guided transdermal injection of anhydrous ethanol in treatment of simple hepatic cyst:a clinical analysis of 83cases[J].J Mod Med Health,2014,30(6):893-894.(in Chinese)范晓英.超声引导下经皮注射无水乙醇治疗单纯性肝囊肿83例临床分析[J].现代卫生医药,2014,30(6):893-894.

[10]KIMURA F,MIYAZAKI M,ITOH H,et al.Repeated instillation of a limited volume of ethanol for the treatment of symptomatic hepatic cysts[J].Hepatogastroenterology,2005,52(64):1147-1150.

[11]ZHANG YQ,YANG WZ,GUO JY,et al.Ultrasound guided injection of poly Gui alcohol in the treatment of renal cysts(reports of 24cases)[J].Med Res Education,2013,30(1):36-38.(in Chinese)张彦桥,杨文增,郭景阳,等.超声引导穿刺注射聚桂醇注射液治疗肾囊肿(附24例报告)[J].医学研究与教育,2013,30(1):36-38.

Relative Articles

[1]	Ronglai CAO, Liang ZHU, Zhengping YU, Jinli HE, Youxiang CHEN. Efficacy and safety of endoscopic retrograde cholangiopancreatography during pregnancy and puerperium： A comparative analysis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2885-2893. doi: 10.3969/j.issn.1001-5256.2023.12.020
[2]	Changzhou LI, Jianhui LI, Xin HAO, Haibin JIANG, Aimin WANG, Haiyang HUA, Jing QI, Jingzhe ZHANG. Treatment of refractory hepatic hydrothorax by intrapleural injection of lauromacrogol: A case report[J]. Journal of Clinical Hepatology, 2021, 37(9): 2177-2179. doi: 10.3969/j.issn.1001-5256.2021.09.033
[3]	Zhang Yu, Tang ShiXiao. Value of serum liver fibrosis markers in the diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2019, 35(11): 2466-2471. doi: 10.3969/j.issn.1001-5256.2019.11.016
[4]	The Society of Interventional Therapy, China Anti-Cancer Association. Expert consensus of percutaneous transhepatic biliary drainage and stent implantation in treatment of obstructive jaundice(2018 Edition)[J]. Journal of Clinical Hepatology, 2019, 35(3): 504-508. doi: 10.3969/j.issn.1001-5256.2019.03.010
[5]	Cui MeiLan, Jia YanSheng, Kang HaiYan, Yin ShuYing, Zheng HuanWei. Efficacy of endoscopic sclerotherapy with lauromacrogol in treatment of severe esophageal variceal bleeding[J]. Journal of Clinical Hepatology, 2017, 33(12): 2321-2325. doi: 10.3969/j.issn.1001-5256.2017.12.013
[6]	Xiong Yong, Wang HeBin, Liu DeQin, Chen JianXun, Liu JianPing, Sun ChangQin. Total laparoscopic hepatectomy versus open hepatectomy in treatment of hepatocellular carcinoma in the left lateral lobe: a case- matched analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 735-738. doi: 10.3969/j.issn.1001-5256.2016.04.026
[7]	Yang Jun, Yu YaLi, Zheng ZhangQing. Clinical features of drug- induced liver injury and primary biliary cirrhosis: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 728-731. doi: 10.3969/j.issn.1001-5256.2016.04.024
[8]	Wang Zhun, Gong TianBin. Efficacy of three liver- protecting drugs commonly used in treatment of drug- induced liver injury: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 761-763. doi: 10.3969/j.issn.1001-5256.2016.04.033
[9]	Li Qiang, Zhuo QiBin, Huang YuXian, Chen Liang. Clinical features of acute hepatitis B and acute exacerbation of chronic hepatitis B: a comparative study[J]. Journal of Clinical Hepatology, 2016, 32(4): 706-710. doi: 10.3969/j.issn.1001-5256.2016.04.019
[11]	Hao Qiao, Xue JianFeng, Tian XiangYong, Hu JunLong. A case of ectopic pancreas in the gastric antrum misdiagnosed as hepatic cyst[J]. Journal of Clinical Hepatology, 2016, 32(11): 2171-2172. doi: 10.3969/j.issn.1001-5256.2016.11.036
[12]	Ji JianFeng, Xiao QiuJin, Deng XiaoLi. Effect of ultrasound- guided percutaneous injection of cinobufotalin or anhydrous ethanol in treatment of portal vein tumor thrombus: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 673-677. doi: 10.3969/j.issn.1001-5256.2016.04.012
[13]	Zheng SuJun, Duan ZhongPing. Current Research on acute-on-chronic liver failure: a comparison between Eastern and Western countries[J]. Journal of Clinical Hepatology, 2015, 31(9): 1400-1404. doi: 10.3969/j.issn.1001-5256.2015.09.009
[14]	Yin Yu, Ni CaiFang, Li Zhi, Tang Jie. Therapeutic comparison between radiofrequency ablation and percutaneous ethanol injection in treatment of primary liver cancer: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(6): 918-921. doi: 10.3969/j.issn.1001-5256.2015.06.022
[15]	Tan ZuYun, Guo YaBing. Comparison of efficacy between sodium morrhuate and lauromacrogol as sclerosing agents in treatment of hepatic cyst[J]. Journal of Clinical Hepatology, 2015, 31(7): 1107-1109. doi: 10.3969/j.issn.1001-5256.2015.07.026
[18]	Wu JianBing, Li Ling, Liu AnWen, Li ChunLai, Hu RongHuan, Lan QiongYu. Trans microcatheter subsegmental chemoembolization of Lipiodol-adriamycin and ethanol to treat small carcinoma of the liver[J]. Journal of Clinical Hepatology, 2005, 21(3): 149-150.
[20]	Ding Sheng, Wang Li, Yan XinMin, Zhou JianYong. Comparison of the diagnosis between CT and B mode ultrasoud in faffy liver.[J]. Journal of Clinical Hepatology, 2002, 18(6): 372-373.

Supplements(0)

Cited By

Cited by

Periodical cited type(26)

1.	赵静，郑爱平. 彩超引导下聚桂醇一次性硬化治疗巨大肝囊肿的效果和安全性. 吉林医学. 2022(11): 2914-2917 .
2.	徐志鸿，段春霞，吴良美. 超声引导下经皮穿刺置管引流结合聚桂醇泡沫硬化治疗肝囊肿的效果分析. 中外医疗. 2021(09): 190-192 .
3.	张颖. 超声介入注射聚桂醇治疗肝肾囊肿患者的有效性分析. 海峡药学. 2021(04): 168-169 .
4.	王瑞芳，程志刚，梁萍. 消融治疗多脏器囊肿的现状及进展. 中华超声影像学杂志. 2021(11): 1001-1006 .
5.	夏天祥，葛晖. 超声引导下无水乙醇联合聚桂醇治疗巨大单纯性肝囊肿的疗效观察. 淮海医药. 2020(01): 1-4 .
6.	覃艳丽，周军. 聚桂醇的临床应用及其不良反应. 中国介入影像与治疗学. 2020(09): 569-572 .
7.	邓魏敏，赵伟强. 超声介入治疗甲状腺囊性结节的临床价值分析. 中外医疗. 2020(21): 193-195 .
8.	高志玲，何峥，吴凡，张鑫，高月求. 超声引导下经皮穿刺置管引流联合聚桂醇泡沫硬化治疗肝囊肿的临床疗效. 中国医师杂志. 2019(03): 448-450 .
9.	方鸿，肖露蓉，宫雪. 超声引导下注射聚桂醇硬化治疗肝肾囊肿的临床效果. 实用临床医药杂志. 2019(12): 5-7 .
10.	马有良，张玉英，马钦风. 超声引导注射聚桂醇与高渗葡萄糖治疗肝囊肿的疗效对比分析. 现代消化及介入诊疗. 2019(05): 526-529 .
11.	向娟，罗涌，王怡，何艳，王邦琼. 超声引导经皮注射无水乙醇与聚桂醇治疗甲状腺囊性结节疗效对比. 中国药业. 2019(18): 56-59 .
12.	裴峰，朱昱思. 较大肝囊肿超声引导下聚桂醇硬化治疗的两种方法比较. 世界最新医学信息文摘. 2019(85): 194+200 .
13.	郁鹏，刘洪兰，吴彦，姜丽娜，王丽娜，史习珍，刘佳. 两种不同硬化剂介入超声下硬化治疗肝囊肿的临床对比分析. 实用医学影像杂志. 2018(02): 103-105 .
14.	杨佳. 彩超引导下经皮无水酒精硬化应用于不同直径肝囊肿的效果. 实用中西医结合临床. 2018(08): 116-118 .
15.	柴振基. 超声介入下囊肿内注入不同硬化剂治疗肝囊肿的临床效果观察. 现代诊断与治疗. 2018(01): 85-86 .
16.	长蒙，姜葵，王邦茂，常毅湘. 超声引导下无水乙醇与聚桂醇硬化治疗较大单纯性肝囊肿的临床疗效对比分析. 世界华人消化杂志. 2018(24): 1463-1469 .
17.	闻玲云. 针对性护理在肝囊肿腹腔镜开窗引流术患者中的应用效果. 西藏医药. 2018(04): 111-112 .
18.	王丽. 肝囊肿与肝脓肿的超声鉴别与引导介入治疗. 影像研究与医学应用. 2018(19): 105-106 .
19.	林元强，刘世军，罗强，王辉. 超声引导下应用聚桂醇和无水乙醇抽吸固化治疗中老年肝肾囊肿的效果. 中国老年学杂志. 2018(12): 2940-2943 .
20.	钟丽兰，刘照宏，涂滨. 系统化健康教育在超声引导下囊肿介入治疗中的应用价值. 中国当代医药. 2018(31): 219-221 .
21.	张峰. 超声引导下聚桂醇与无水乙醇硬化治疗单纯性肝囊肿的疗效及不良反应的比较. 航空航天医学杂志. 2017(04): 452-453 .
22.	储仁华. 超声介入穿刺注射聚桂醇应用于临床治疗肝囊肿患者的效果探究. 中外医疗. 2017(31): 179-181 .
23.	刘静，孟庆欣，崔启超，杨瑞，陈鑫. 超声引导下经皮穿刺聚桂醇注射液与无水乙醇硬化治疗单纯性肝囊肿的疗效对比研究. 现代生物医学进展. 2017(29): 5681-5685+5672 .
24.	王丹，何冠南. 超声引导下聚桂醇硬化治疗在复发性卵巢巧克力囊肿中的应用. 山西医药杂志. 2017(11): 1340-1342 .
25.	程嘉，何海滨. 超声引导经皮穿刺聚桂醇注射治疗甲状腺囊肿50例的效果分析. 中国民康医学. 2017(22): 105-106 .
26.	李丽娜，于风琴，初晓倩. 超声引导下聚桂醇与无水乙醇硬化治疗卵巢囊肿的比较. 人人健康. 2016(23): 66 .

Other cited types(4)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (474) PDF downloads(323)

Clinical effect of ultrasound-guided injection of lauromacrogol versus anhydrous ethanol as sclerotherapy for simple hepatic cyst:a therapeutic effect analysis and comparative study

DOI: 10.3969/j.issn.1001-5256.2016.06.029